RAF1 and neoplasm: Lessons learned from efforts to inhibit the RAS-RAF-MEK pathway in other tumor types have revealed that a major mechanism of resistance is the adaptive feedback resistance, in which the loss of downstream signaling by the blocked mutant target, leads to reactivation of receptor tyrosine kinase (RTK) mediated signaling through wild type RAS and RAF (39).